Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

ROIV

Insider Sentiment (TTM):

Last Purchase:2025-09-18Last Sale:2026-06-30Shares Purchased (TTM):3,315Shares Sold (TTM):17,323,453

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:518,747,156Shares Outstanding:693,864,530Institutional Ownership Pct.:74.76%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1,248	1,419	1,478	1,237	1,238	2,715	1,991	1,959	5,679	6,495	6,671	1,408
Marketable Securities Current	2,594	2,873	3,052	3,149	3,265	2,171	3,156	3,428	-	0	-	-
Other Assets Current	128	105	130	126	113	113	217	94	323	81	136	143
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	0	0	320	-	156	-	-
Assets Current	4,742	5,167	4,660	4,512	4,616	5,000	5,364	5,801	6,001	6,732	6,807	1,552
Property Plant And Equipment Net	11	12	13	26	15	12	14	14	18	15	22	24
Operating Lease Right Of Use Asset	79	80	84	85	87	89	91	43	45	44	47	49
Investments Fair Value Disclosure	445	408	434	412	284	303	290	311	263	248	240	250
Intangible Assets Net Excluding Goodwill	-	-	-	-	-	-	-	-	136	138	150	141
Other Assets Noncurrent	30	41	35	28	31	33	34	37	33	38	47	50
Assets	5,306	5,709	5,225	5,063	5,033	5,437	5,792	6,206	6,496	7,222	7,313	2,066
Disposal Group Including Discontinued Operation As…	-	-	-	-	-	0	0	0	-	146	-	-
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	25	18	13	15	12	24	24	25	28	14	35	44
Accrued Liabilities Current	169	206	118	108	89	114	104	111	138	119	122	153
Operating Lease Liability Current	12	11	10	9	9	10	10	10	9	9	10	11
Long Term Debt Current	-	-	-	-	-	-	-	-	12	12	46	49
Taxes Payable Current	-	46	-	-	-	0	-	-	-	-	-	-
Other Liabilities Current	3	1	10	1	4	1	4	9	28	14	31	9
Liabilities Current	284	281	152	134	114	149	141	556	215	267	245	266
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	0	0	401	-	110	-	-
Operating Lease Liability Noncurrent	95	96	99	90	90	90	90	43	46	45	47	49
Long Term Debt	-	-	-	-	-	-	-	-	312	431	403	389
Other Liabilities Noncurrent	6	0	1	0	0	0	0	0	2	2	4	5
Liabilities	385	416	251	257	217	250	256	626	601	774	728	740
Liabilities Of Disposal Group Including Discontinu…	-	-	-	-	-	0	0	0	-	434	-	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	5,131	5,025	4,944	4,772	4,644	4,562	4,721	4,775	4,782	5,396	5,390	5,321
Retained Earnings Accumulated Deficit	-900	-502	-695	-429	-316	116	460	396	671	576	727	-4,369
Accumulated Other Comprehensive Income Loss Net Of…	1	4	21	20	17	9	8	-18	-18	-4	-28	-3
Stockholders Equity	4,231	5,292	4,269	4,805	4,816	4,688	5,536	5,580	5,435	6,449	6,585	949
Minority Interest	691	765	705	443	470	500	346	427	460	480	495	377
Liabilities And Stockholders Equity	5,306	5,709	5,225	5,063	5,033	5,437	5,792	6,206	6,496	7,222	7,313	2,066
Shortterm Debt Fair Value	-	-	-	-	-	-	-	-	6	6	27	28
Long Term Debt Fair Value	-	-	-	-	-	-	-	-	82	204	195	189
Available For Sale Securities Debt Securities	-	-	-	2,789	1,803	-	-	-	-	-	-	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000	7,000
Common Stock Shares Issued	723	720	710	690	682	696	720	733	739	807	805	801
Shares Outstanding	723	720	710	690	682	696	720	733	739	807	805	801

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2027	-	-	-	-	-	-	-	-	-	-	-	-
2026	15.67%	44.76%	78.96%	-0.94%	3.59%	2.13%	12.08%	2.71%	6.16%	-7.31%	10.98%	-
2025	9.98%	3.24%	7.19%	6.19%	0.43%	-4.38%	-1.39%	-12.33%	6.39%	1.33%	1.24%	4.87%
2024	7.60%	-7.77%	-20.75%	8.62%	24.53%	9.28%	-1.11%	8.70%	5.46%	2.89%	5.87%	7.70%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	16.72	18.37	30.66	33.70	40.54	33.47	37.91	10.43	27.91	25.24	27.79	5.84
Quick Ratio	16.72	18.37	30.66	33.70	40.54	33.47	37.91	10.43	27.91	25.24	27.79	5.84
Working Capital	4.46B	4.89B	4.51B	4.38B	4.50B	4.85B	5.22B	5.24B	5.79B	6.47B	6.56B	1.29B
Leverage & Debt
Debt to Equity	0.09	0.08	0.06	0.05	0.04	0.05	0.05	0.11	0.11	0.12	0.11	0.78
Interest Coverage TTM	-	-	-	-	-	-74.88	-41.72	151.36	118.97	129.31	121.70	-31.34
Debt Ratio	0.07	0.07	0.05	0.05	0.04	0.05	0.04	0.10	0.09	0.11	0.10	0.36
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.03
Per Share Metrics
Diluted EPS TTM	-0.44	-0.57	-1.37	-0.77	-1.01	-0.49	-0.23	6.47	6.06	5.23	5.12	-1.46
Free Cash Flow Per Share TTM	-1.44	-0.85	-0.86	-0.89	-0.69	-1.16	-1.08	-1.06	-0.97	-0.98	-1.05	-1.10
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	-105.80%	-6.31%	46.96%	49.53%
Operating Profit Margin TTM	-7,914.75%	-6,235.69%	-9,130.53%	-5,659.41%	-5,104.73%	-3,453.32%	-6,424.55%	22,824.21%	24,483.52%	13,746.93%	6,455.04%	-1,581.85%
Net Profit Margin TTM	-4,166.66%	-4,817.28%	-7,190.10%	-2,566.43%	-2,961.89%	-1,227.87%	-1,258.34%	23,905.68%	24,813.99%	13,294.18%	6,339.19%	-1,612.96%
Growth Metrics
Net Revenue Growth (1Y)	-67.58%	-71.57%	-0.39%	2.12%	21.77%	-11.19%	-80.41%	-71.44%	-75.72%	-46.62%	58.16%	38.25%
Net Income Growth (1Y)	-54.39%	11.54%	469.17%	-110.96%	-114.54%	-108.20%	-103.89%	-523.28%	-525.93%	-489.88%	-436.33%	-9.31%
EPS Growth (1Y)	-56.96%	16.61%	490.29%	-111.84%	-115.72%	-108.86%	-104.31%	-543.28%	-539.51%	-454.80%	-399.67%	-17.60%
Valuation Metrics
P/E TTM	-81.28	-48.30	-15.80	-19.75	-11.14	-20.52	-50.85	1.78	1.64	1.90	2.08	-8.00
P/B TTM	6.03	3.63	3.54	2.14	1.59	1.41	1.54	1.52	1.43	1.28	1.37	9.48
P/S TTM	3,386.66	2,326.88	1,136.13	506.80	330.00	251.93	639.85	426.37	407.65	252.36	131.81	129.07
Market Cap	25.51B	19.22B	15.12B	10.30B	7.67B	7.32B	8.55B	8.49B	7.78B	8.26B	8.99B	9.00B
Enterprise Value	24.26B	17.80B	13.64B	9.07B	6.43B	4.60B	6.56B	6.53B	2.40B	2.14B	2.71B	7.96B
Calculated Values
Free Cash Flow TTM	-1.04B	-590.61M	-598.91M	-606.57M	-472.44M	-844.05M	-779.48M	-781.21M	-710.11M	-766.65M	-838.55M	-850.85M
Net Debt	-1.25B	-1.42B	-1.48B	-1.24B	-1.24B	-2.72B	-1.99B	-1.96B	-5.38B	-6.12B	-6.28B	-1.03B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-30Sale

Owner: Qvt, Financial Lp

Title: -

Shares: 12,380

Price/Share: $35.28

Value: $436,766.40

Shares Owned: 13,689,166

Relationship: Other

Ownership: Indirect

2026-06-30Sale

Owner: Gold, Daniel Allen

Title: -

Shares: 12,380

Price/Share: $35.28

Value: $436,766.40

Shares Owned: 13,689,166

Relationship: Director

Ownership: Indirect

2026-06-30Sale

Owner: Manchester, Keith S

Title: -

Shares: 200,000

Price/Share: $35.45

Value: $7,090,000.00

Shares Owned: 1,748,403

Relationship: Director

Ownership: Direct

2026-06-26Sale

Owner: Sukhatme, Mayukh

Title: President & CIO

Shares: 500,000

Price/Share: $34.08

Value: $17,040,000.00

Shares Owned: 18,677,617

Relationship: Director,Officer

Ownership: Direct

2026-06-24Sale

Owner: Venker, Eric

Title: President & Immunovant CEO

Shares: 200,000

Price/Share: $33.28

Value: $6,656,000.00

Shares Owned: 1,613,063

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-30	Qvt, Financial Lp	Other	-	Indirect	Sale	12,380	35.28	$436,766.40	13,689,166	4
2026-06-30	Gold, Daniel Allen	Director	-	Indirect	Sale	12,380	35.28	$436,766.40	13,689,166	4
2026-06-30	Manchester, Keith S	Director	-	Direct	Sale	200,000	35.45	$7,090,000.00	1,748,403	4
2026-06-26	Sukhatme, Mayukh	Director,Officer	President & CIO	Direct	Sale	500,000	34.08	$17,040,000.00	18,677,617	4
2026-06-24	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	33.28	$6,656,000.00	1,613,063	4
2026-05-22	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	30.27	$6,054,000.00	1,613,063	4
2026-04-20	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	29.59	$5,918,000.00	1,647,546	4
2026-04-16	Gline, Matthew	Director,Officer	CEO	Direct	Sale	289,774	29.16	$8,449,809.84	16,736,116	4
2026-04-08	Humes, Jennifer	Officer	Chief Accounting Officer	Direct	Sale	13,538	28.37	$384,073.06	84,191	4
2026-03-26	Fitzgerald, Meghan	Director	-	Direct	Sale	70,000	27.45	$1,921,500.00	42,963	4
2026-03-17	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	28.24	$5,648,000.00	1,647,546	4
2026-03-16	Epperly, Melissa B,	Director	-	Direct	Sale	41,861	28.68	$1,200,573.48	15,804	4
2026-02-19	Torti, Frank	Officer	President and Vant Chair	Direct	Sale	1,400,000	27.42	$38,388,000.00	13,736,547	4
2026-02-13	Manchester, Keith S	Director	-	Indirect	Sale	375,784	26.49	$9,954,518.16	15,127,329	4
2026-02-13	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	26.49	$5,298,000.00	1,654,597	4
2026-02-13	Qvt, Financial Lp	Other	-	Indirect	Sale	375,784	26.49	$9,954,518.16	15,127,329	4
2026-02-12	Gold, Daniel Allen	Director	-	Indirect	Sale	425,000	26.74	$11,364,500.00	15,503,113	4
2026-02-09	Sukhatme, Mayukh	Director,Officer	President & CIO	Direct	Sale	339,441	26.47	$8,985,003.27	19,148,664	4
2026-01-12	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	21.92	$4,384,000.00	1,654,597	4
2025-12-31	Sukhatme, Mayukh	Director,Officer	President & CIO	Direct	Sale	1,018,995	21.71	$22,122,381.45	20,267,429	4
2025-12-24	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	75,000	22.53	$1,689,750.00	1,654,597	4
2025-12-23	Pulik, Richard	Officer	CFO	Direct	Sale	406,731	22.42	$9,118,909.02	239,413	4
2025-12-17	Qvt, Financial Lp	Other	-	Indirect	Sale	777,332	23.08	$17,940,822.56	16,353,113	4
2025-12-17	Gold, Daniel Allen	Director	-	Indirect	Sale	777,332	23.08	$17,940,822.56	16,353,113	4
2025-12-17	Sukhatme, Mayukh	Director,Officer	President & CIO	Direct	Sale	26,831	23.09	$619,527.79	18,869,229	4
2025-12-17	Manchester, Keith S	Director	-	Indirect	Sale	777,332	23.08	$17,940,822.56	16,353,113	4
2025-12-15	Ramaswamy, Vivek	TenPercentOwner	-	Direct	Sale	353,745	22.05	$7,800,077.25	34,132,463	4
2025-12-15	Gline, Matthew	Director,Officer	CEO	Direct	Sale	1,740,000	21.68	$37,723,200.00	17,290,820	4
2025-12-09	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	20.85	$4,170,000.00	1,497,908	4
2025-11-19	Manchester, Keith S	Director	-	Indirect	Sale	1,300,000	20.21	$26,273,000.00	18,047,727	4
2025-11-19	Qvt, Financial Lp	Other	-	Indirect	Sale	1,300,000	20.21	$26,273,000.00	18,047,727	4
2025-11-19	Gold, Daniel Allen	Director	-	Indirect	Sale	1,300,000	20.21	$26,273,000.00	18,047,727	4
2025-11-17	Ramaswamy, Vivek	TenPercentOwner	-	Direct	Sale	539,650	20.51	$11,068,221.50	33,653,756	4
2025-11-07	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	200,000	20.22	$4,044,000.00	1,504,959	4
2025-10-17	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	118,418	17.06	$2,020,211.08	1,504,959	4
2025-10-13	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	20,727	16.25	$336,813.75	1,504,959	4
2025-10-08	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	138,602	16.20	$2,245,352.40	1,504,959	4
2025-09-23	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	611,000	14.83	$9,061,130.00	1,504,959	4
2025-09-18	Gline, Matthew	Director,Officer	CEO	Direct	Purchase	3,315	15.07	$49,957.05	17,287,081	4
2025-09-05	Ramaswamy, Vivek	TenPercentOwner	-	Direct	Sale	385,816	12.96	$5,000,175.36	35,508,359	4
2025-08-20	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	100,000	11.72	$1,172,000.00	1,653,585	4
2025-07-21	Venker, Eric	Officer	President & Immunovant CEO	Direct	Sale	100,000	11.52	$1,152,000.00	1,462,223	4
2025-06-20	Ramaswamy, Vivek	TenPercentOwner	-	Direct	Sale	577,007	11.46	$6,612,500.22	37,284,108	4
2025-06-20	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	11.45	$1,145,000.00	1,462,223	4
2025-06-06	Ramaswamy, Vivek	TenPercentOwner	-	Direct	Sale	200,800	11.19	$2,246,952.00	38,426,381	4
2025-06-03	Venker, Eric	Officer	President & COO	Direct	Sale	566,278	11.22	$6,353,639.16	1,462,223	4
2025-05-20	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	10.95	$1,095,000.00	1,077,197	4
2025-05-07	Ramaswamy, Vivek	TenPercentOwner	-	Direct	Sale	625,000	11.18	$6,987,500.00	39,174,611	4
2025-04-21	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	10.22	$1,022,000.00	1,116,345	4
2025-03-24	Venker, Eric	Officer	President & COO	Direct	Sale	434,478	10.82	$4,701,051.96	1,127,290	4
2025-02-20	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	10.65	$1,065,000.00	896,869	4
2025-02-13	Kumar, Rakhi	Officer	Chief Accounting Officer	Direct	Sale	227,500	10.43	$2,372,825.00	163,264	4
2025-02-13	Venker, Eric	Officer	President & COO	Direct	Sale	218,041	10.42	$2,271,987.22	896,869	4
2025-01-21	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	11.28	$1,128,000.00	732,294	4
2024-12-30	Venker, Eric	Officer	President & COO	Direct	Sale	177,704	11.54	$2,050,704.16	740,976	4
2024-12-26	Sukhatme, Mayukh	Director,Officer	Pres&Chief Investment Officer	Direct	Sale	689,495	12.01	$8,280,834.95	18,836,547	4
2024-12-20	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	11.49	$1,149,000.00	595,580	4
2024-12-18	Sukhatme, Mayukh	Director,Officer	Pres&Chief Investment Officer	Direct	Sale	412,584	12.05	$4,971,637.20	18,836,547	4
2024-11-20	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	11.32	$1,132,000.00	606,525	4
2024-10-21	Venker, Eric	Officer	President & COO	Direct	Sale	100,000	11.65	$1,165,000.00	617,470	4
2024-09-26	Qvt, Financial Lp	Other	-	Indirect	Sale	876,000	11.82	$10,354,320.00	22,179,358	4
2024-09-26	Gold, Daniel Allen	Director	-	Indirect	Sale	876,000	11.82	$10,354,320.00	22,179,358	4
2024-09-25	Manchester, Keith S	Director	-	Direct	Sale	134,948	11.77	$1,588,337.96	1,277,178	4
2024-09-23	Kumar, Rakhi	Officer	Chief Accounting Officer	Direct	Sale	250,000	11.89	$2,972,500.00	209,322	4
2024-09-23	Gline, Matthew	Director,Officer	CEO	Direct	Sale	1,983,257	11.79	$23,382,600.03	17,870,543	4
2024-02-09	Venker, Eric	Officer	President & COO	Direct	Sale	96,950	10.92	$1,058,694.00	532,207	4
2024-01-02	Ramaswamy, Vivek	TenPercentOwner	-	Direct	Sale	3,000,000	11.05	$33,150,000.00	51,929,426	4
2023-10-05	Venker, Eric	Officer	Chief Operating Officer	Direct	Sale	153,027	10.11	$1,547,102.97	595,397	4
2023-09-28	Svf, Investments (Uk) Ltd…	TenPercentOwner	-	Indirect	Sale	10,000,000	12.60	$126,000,000.00	73,031,667	4
2023-09-28	Manchester, Keith S	Director	-	Indirect	Sale	6,896,144	11.55	$79,650,463.20	5,023,787	4
2023-09-28	Qvt, Financial Lp	TenPercentOwner,Other	-	Indirect	Sale	10,000,000	11.55	$115,500,000.00	100,804	4
2023-09-28	Gold, Daniel Allen	Director	-	Indirect	Sale	10,000,000	11.55	$115,500,000.00	100,804	4
2023-09-27	Venker, Eric	Officer	President & COO	Direct	Sale	500,000	13.02	$6,510,000.00	595,397	4
2023-09-08	Kumar, Rakhi	Officer	Chief Accounting Officer	Direct	Sale	99,350	12.18	$1,210,083.00	197,950	4
2023-09-08	Venker, Eric	Officer	Chief Operating Officer	Direct	Sale	106,430	12.19	$1,297,381.70	611,813	4
2023-09-06	Venker, Eric	Officer	Chief Operating Officer	Direct	Sale	5,926	11.85	$70,223.10	611,813	4
2023-09-05	Kumar, Rakhi	Officer	Chief Accounting Officer	Direct	Sale	1,724	12.00	$20,688.00	197,950	4
2023-08-14	Venker, Eric	Officer	Chief Operating Officer	Direct	Sale	59,811	11.89	$711,152.79	627,918	4
2023-08-03	Kumar, Rakhi	Officer	Chief Accounting Officer	Direct	Sale	3,681	12.00	$44,172.00	199,328	4
2023-08-03	Venker, Eric	Officer	Chief Operating Officer	Direct	Sale	44,629	11.93	$532,423.97	627,918	4
2023-08-02	Venker, Eric	Officer	Chief Operating Officer	Direct	Sale	16,397	11.86	$194,468.42	627,918	4
2023-07-27	Venker, Eric	Officer	Chief Operating Officer	Direct	Sale	23,622	10.98	$259,369.56	627,918	4
2023-07-24	Venker, Eric	Officer	President & COO	Direct	Sale	33,081	10.93	$361,575.33	644,215	4
2023-07-18	Kumar, Rakhi	Officer	Chief Accounting Officer	Direct	Sale	100	12.00	$1,200.00	82,128	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

74.76%

Inst. Shares: 518,747,156

Shares Outstanding: 693,864,530

2025-12-31

71.90%

Inst. Shares: 501,020,909

Shares Outstanding: 696,859,682

2025-09-30

72.88%

Inst. Shares: 496,254,031

Shares Outstanding: 680,947,866

2025-06-30

74.63%

Inst. Shares: 507,703,749

Shares Outstanding: 680,286,922

2025-03-31

75.25%

Inst. Shares: 545,865,442

Shares Outstanding: 725,395,624

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	518,747,156	693,864,530	74.76%
2025-12-31	501,020,909	696,859,682	71.90%
2025-09-30	496,254,031	680,947,866	72.88%
2025-06-30	507,703,749	680,286,922	74.63%
2025-03-31	545,865,442	725,395,624	75.25%
2024-12-31	555,150,359	722,716,168	76.81%
2024-09-30	556,483,570	735,470,796	75.66%
2024-06-30	536,924,430	735,816,536	72.97%
2024-03-31	518,855,072	783,248,906	66.24%
2023-12-31	530,935,969	800,587,716	66.32%
2023-09-30	520,624,400	770,227,849	67.59%
2023-06-30	489,682,575	759,273,550	64.49%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Roivant Sciences Ltd. (ROIV) — SEC Financial Statements & Analysis

Roivant Sciences Ltd. (ROIV) is a pharmaceutical preparations company, incorporated in D0. Roivant Sciences Ltd. trades on Nasdaq as: ROIV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Roivant Sciences Ltd. reported a -67.58% year-over-year revenue growth, a Gross Profit Margin of -105.80% (TTM), a Debt-to-Equity ratio of 0.09x, a Price-to-Sales (P/S) ratio of 3386.66x (TTM), a Price-to-Book (P/B) ratio of 6.03x (TTM), at a market cap of $25.51B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -67.58%
Gross Profit Margin TTM: -105.80%
Debt To Equity: 0.09x
P/S TTM: 3386.66x
P/B TTM: 6.03x
Market Cap: $25.51B

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Roivant Sciences Ltd. in?

Roivant Sciences Ltd. (ROIV) operates in the Pharmaceutical Preparations industry.

What is ROIV's market cap?

Roivant Sciences Ltd. (ROIV) has a market capitalization of $25.51B as of 2026-06-30.

What exchange does ROIV trade on?

Roivant Sciences Ltd. (ROIV) trades on the Nasdaq.

Where is Roivant Sciences Ltd. incorporated?

Roivant Sciences Ltd. is incorporated in Bermuda.